The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $47.47

Today's change+0.21 +0.44%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.
 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $47.47

Today's change+0.21 +0.44%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Neogen Corp up (U.S.)$0.21

Neogen Corp closed up Friday by (U.S.)$0.21 or 0.44% to (U.S.)$47.47. Over the last five days, shares have lost 3.77% and are down 16.01% for the last year to date. This security has outperformed the S&P 500 by 9.57% during the last year.

Key company metrics

  • Open(U.S.) $47.71
  • Previous close(U.S.) $47.26
  • High(U.S.) $48.00
  • Low(U.S.) $46.89
  • Bid / Ask-- / --
  • YTD % change-16.01%
  • Volume216,092
  • Average volume (10-day)174,184
  • Average volume (1-month)175,733
  • Average volume (3-month)175,055
  • 52-week range(U.S.) $41.51 to (U.S.) $62.70
  • Beta1.44
  • Trailing P/E50.70×
  • P/E 1 year forward45.90×
  • Forward PEG3.40×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.94
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.70%

Based on its net profit margin of 11.70%, Neogen Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedNov 30, 201511/30/2015Aug 31, 201508/31/2015May 31, 201505/31/2015Feb 28, 201502/28/2015
Revenue80757968
Total other revenue--------
Total revenue80757968
Gross profit38383834
Total cost of revenue41374135
Total operating expense65606456
Selling / general / administrative21202119
Research & development3322
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income15151512
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax14141412
Income after tax9997
Income tax, total5554
Net income9997
Total adjustments to net income--------
Net income before extra. items9997
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9997
Inc. avail. to common incl. extra. items9997
Diluted net income9998
Dilution adjustment------0
Diluted weighted average shares38383838
Diluted EPS excluding extraordinary itemsvalue per share0.240.250.250.20
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.240.250.250.20